1-2 of 2
Adrienne M Dorrance, Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Mir-155 via The NEDD8-Activating Enzyme Inhibitor MLN4924: A Novel Therapeutic Approach For Acute Myeloid Leukemia (AML)

Jihane C Khalife, MS, Hanna S Radomska, PhD, Jennifer Saultz, MD, Ramasamy Santhanam, PhD, Xiaomeng Huang, Hongyan Wang, PhD, John P. Curfman, Yue-Zhong Wu, MS, Pia Hoellerbauer, Houda Alachkar, PharmD, PhD, Adrienne M Dorrance, Ph.D, Michael A. Caligiuri, MD, Ramiro Garzon, MD, Jason H. Mendler, MD, PhD, Guido Marcucci, MD
Journal: Blood
Blood (2013) 122 (21): 3804.
https://doi.org/10.1182/blood.V122.21.3804.3804
Published: 2013
Journal Articles

SPARC contributes to Leukemia Growth and Aggressive Disease in Acute Myeloid Leukemia (AML)

Houda Alachkar, PharmD, Kati Maharry, MAS, Ramasamy Santhanam, Ph.D, Paolo Neviani, Ph.D, Stefano Volinia, PhD, Jessica Kohlschmidt, PhD, Klaus H. Metzeler, MD, Adrienne M Dorrance, Ph.D, Sebastian Schwind, MD, Heiko Becker, MD, Jason H. Mendler, MD, PhD, Ann-Kathrin Eisfeld, MD, Susan Whitman, PhD, Krzysztof Mrózek, MD, PhD, Ramiro Garzon, MD, Danilo Perrotti, MD, Ph.D, Michael A. Caligiuri, M.D., Richard M. Stone, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2012) 120 (21): 773.
https://doi.org/10.1182/blood.V120.21.773.773
Published: 2012